Accumulating evidence indicates that excessive ROS levels can induce cancer cell death by modulating c-Jun-N-terminal kinase (JNK), a stress-associated protein kinase belonging to mitogen-activated protein kinase family11 thus suggesting that targeting ROS/JNK signaling pathway might represent an effective strategy for cancer treatment. This evidence concerns the gene WNK2 and cancer.